BiotechTube
Home/Cellectis/Stéphane Depil
SD

Stéphane Depil

SVP, Research & Development

Cellectis

Therapeutic Areas

OncologyGenetic Diseases

Cellectis Pipeline

DrugIndicationPhase
lasme-cel (UCART22)Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL)Phase 2
UCART20x22Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Phase 1/2a
UCART123Acute Myeloid Leukemia (AML) & Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase 1

Leadership Team at Cellectis

AC
André Choulika
Founder, Chief Executive Officer, Chairman
BW
Bing Wang
Chief Medical Officer
AH
Axel Hoos
CEO of Cellectis Therapeutics
DS
David Sourdive
EVP, Technical Operations
View full Cellectis profile